Pudumjee Paper Products DuPont analysis

·OthersChart ›
Per cent unless marked ×
Tap a line for its trendLast 12Mto Sep 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.74×0.74×0.74×0.75×0.75×
1.20×1.17×1.16×1.07×1.06×
13.2%13.4%13.7%15.7%9.9%
0.96×0.96×1.09×1.17×1.24×
1.37×1.37×1.31×1.45×1.58×
15.3%15.3%16.9%21.2%15.3%
15.0%15.0%17.8%22.1%16.1%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

PDMJEPAPER₹87.50

Pudumjee Paper Products Limited

· Others
₹ CrorePeersNRAILTNPLANDHRAPAPKUANTUMSATIASESHAPAPERRAMANEWSPAKKAMcap ₹831 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.750.750.740.740.74
Interest Burden (Pretax/EBIT) ×1.061.071.161.171.20
EBIT Margin %9.8915.7113.7213.3813.16
Asset Turnover ×1.241.171.090.960.96
Financial Leverage (Assets/Equity) ×1.581.451.311.371.37
ROE (5-step product, year-end total equity) %15.3121.2316.9015.2915.27
ROE (owners' profit / average owners' equity) %16.0622.0717.8114.9514.95
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.